Literature DB >> 3588837

Repair and fixation of potentially lethal damage (PLD) as demonstrated by delayed plating or incubation with araA in contact inhibited refed plateau-phase C3H mouse embryo 10 T1/2 cells grown in the presence of BrdUrd.

G Iliakis, E Wright, F Q Ngo.   

Abstract

C3H mouse 10 T1/2 cells showing strong inhibition of growth at confluency were grown under daily refeeding in the presence of BrdUrd (from 0 to 1 microM) and exposed to gamma-rays either while exponentially growing or in the plateau phase. An increase in radiosensitivity was observed in both growth conditions mainly reflected by a reduction in Dq. Greater radiosensitization was observed in exponentially growing than in plateau-phase cells, and 3-4 times higher BrdUrd concentrations were required in plateau-phase cells for similar potentiation in killing. This effect could not be entirely attributed to a reduction in BrdUrd incorporation since measurements with 3H-BrdUrd showed reductions in incorporation between only 17-47% in plateau-phase cells. The rate of repair of potentially lethal damage (PLD) as demonstrated by delayed plating was not affected by the incorporation of BrdUrd, but the amount of repair (measured as the relative increase in cell survival) was higher for BrdUrd-containing cells. Post-irradiation treatment of cells in the plateau-phase (no BrdUrd) with 9-beta-D-arabinofuranosyladenine (araA) caused fixation of radiation-induced PLD. AraA treatment of cells grown in the presence of various amounts of BrdUrd also caused fixation of PLD, but resulted in survival levels similar to those observed with cells growing in BrdUrd-free medium. This result indicates that BrdUrd mediated radiosensitization cannot be observed when cells are prevented from repairing PLD by postirradiation incubation with araA. Based on these findings we propose that the mechanism of radiosensitization by BrdUrd incorporation might be, by increasing probability of fixation, mediated by the postirradiation progression of cells through the cycle, of a sector of PLD also sensitive to post-irradiation treatment with araA. For this sector of PLD the term alpha-PLD has been proposed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3588837     DOI: 10.1007/bf01211364

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  44 in total

1.  THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES.

Authors:  S S Cohen; J G Flaks; H D Barner; M R Loeb; J Lichtenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1958-10-15       Impact factor: 11.205

2.  Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.

Authors:  R L Davidson; D Horn
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

3.  Increase in radiosensitivity to ionizing radiation related to replacement of thymidine in mammalian cells with 5-bromodeoxyuridine.

Authors:  W C Dewey; R M Humphrey
Journal:  Radiat Res       Date:  1965-12       Impact factor: 2.841

4.  Potentiation of x-ray killing by 5-bromodeoxyuridine in Chinese hamster cells: a reduction in capacity for sublethal damage accumulation.

Authors:  W U Shipley; M M Elkind; W B Prather
Journal:  Radiat Res       Date:  1971-08       Impact factor: 2.841

5.  DNA double-strand breaks generated by the repair of X-ray damage in Chinese hamster cells.

Authors:  G Ahnström; P E Bryant
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1982-06

6.  Evidence that repair and expression of potentially lethal damage cause the variations in cell survival after X irradiation observed through the cell cycle in Ehrlich ascites tumor cells.

Authors:  G Iliakis; M Nüsse
Journal:  Radiat Res       Date:  1983-07       Impact factor: 2.841

Review 7.  Clinical use of radiation sensitizing agents.

Authors:  D R Goffinet; M A Bagshaw
Journal:  Cancer Treat Rev       Date:  1974-03       Impact factor: 12.111

8.  Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.

Authors:  J K Christman; S Silagi; E W Newcomb; S C Silverstein; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

9.  Evidence for similarities between radiation damage expressed by beta-araA and damage involved in the interaction effect observed after exposure of V79 cells to mixed neutrons and gamma radiation.

Authors:  G Iliakis; F Q Ngo; W K Roberts; K Youngman
Journal:  Radiat Res       Date:  1985-12       Impact factor: 2.841

10.  A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer.

Authors:  T J Kinsella; A Russo; J B Mitchell; J M Collins; J Rowland; D Wright; E Glatstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-11       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.